Literature DB >> 2561119

Clinical experience of Oka-strain live varicella vaccine.

H Kamiya, T Ihara.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2561119     DOI： 10.1007/BF02722369

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  7 in total

1.  Development of a live attenuated varicella vaccine.

Authors:  M Takahashi; Y Okuno; T Otsuka; J Osame; A Takamizawa
Journal:  Biken J       Date:  1975-03

2.  Clinical use of Oka live varicella vaccine.

Authors:  H Kamiya; M Sakurai; T Ihara; M Ito; S Torigoe; Y Ota; T Kamiya; K Horiuchi; Y Asano; K Baba
Journal:  Acta Paediatr Jpn       Date:  1988-10

Review 3.  Worldwide experience with the Oka-strain live varicella vaccine.

Authors:  F E Andre
Journal:  Postgrad Med J       Date:  1985       Impact factor: 2.401

4.  Persistence of protective immunity after inoculation with live varicella vaccine (strain Oka).

Authors:  Y Asano; T Nagai; T Miyata; T Yazaki; S Ito; K Yamanishi; M Takahashi
Journal:  Biken J       Date:  1984-09

5.  Population-based study of herpes zoster and its sequelae.

Authors:  M W Ragozzino; L J Melton; L T Kurland; C P Chu; H O Perry
Journal:  Medicine (Baltimore)       Date:  1982-09       Impact factor: 1.889

6.  Live attenuated varicella virus vaccine. Efficacy trial in healthy children.

Authors:  R E Weibel; B J Neff; B J Kuter; H A Guess; C A Rothenberger; A J Fitzgerald; K A Connor; A A McLean; M R Hilleman; E B Buynak
Journal:  N Engl J Med       Date:  1984-05-31       Impact factor: 91.245

7.  Live attenuated varicella vaccine. Efficacy for children with leukemia in remission.

Authors:  A A Gershon; S P Steinberg; L Gelb; G Galasso; W Borkowsky; P LaRussa; A Farrara
Journal:  JAMA       Date:  1984-07-20       Impact factor: 56.272
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.